4ZHANG Y W, LI R M,ZHANG X W,et al. Current adoptive im- munotherapy in non-small cell lung cancer and potential influence of therapy outcome [ J]. Cancer Invest, 2013, 31 (3) : 197-205. DOI: 10. 3109/07357907. 2013. 775294.
5TUCKER Z C,LAGUNA B A,MOON E,et al. Adjuvant immuno-therapy for non-small cell lung cancer [ J ]. Cancer Treat Rev, 2012, 38 (6) : 650-661. DOI : 10. lO16/j, ctrv. 2011.11. 008.
6MELLMAN I,COUKOS G,DRANOFF G. Cancer immunotherapy comes of age [J]. Nature, 2011, 480(7378): 480489. DOI: 10. 1038/nature10673.
7EUBEL J, ENK A H. Dendritic cell vaccination as a treatment modality for melanoma [J]. Expert Rev Anticancer Ther, 2009,9 (11) : 1631-1642. DOI: 10. 1586/era. 09. 139.
8BERNTSEN A, TREPIAKAS R, WENANDY L, et al. Therapeu- tic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial [ J]. J Immunother, 2008, 31 (8) : 771-780. DOI: 10. 1097/CJI. 0b013e3181833818.
9RAMAKRISHNAN R, GABRILOVICH D I. Mechanism of syner- gistic effect of chemotherapy and immunotherapy of cancer [ J ]. Cancer Immunol lmmunother,2011,60(3) : 419-423. DOI: 10. 1007/s00262-010-0930-1. Epub 2010 Oct 26.
10RICHARDS L. Chemotherapy: conventional chemotherapy boosts the effect of cancer vaccines [J]. Nat Rev Clin Oncol, 2010, 7 (6) : 297-305. DOI: 10. 1038/nrclinonc. 2010.73.
